ALPINE IMMUNE SCIENCES INC (ALPN) Stock Income Statement
NASDAQ:ALPN - Nasdaq - US02083G1004 - Common Stock - Currency: USD
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 56.52M | 58.88M | 30.06M | 23.44M | 9.34M | |||
| Operating Expenses | 107.87M | 103.13M | 88.21M | 73.30M | 38.08M | |||
| Research and Development | 83.78M | 80.90M | 70.24M | 58.74M | 27.19M | |||
| Selling, General, and Administrative Expenses | 24.09M | 22.22M | 17.97M | 14.56M | 10.90M | |||
| Operating Income | -51.36M | -44.25M | -58.15M | -49.86M | -28.75M | |||
| Interest Income/Expense | 14.19M | 11.75M | 2.81M | -560.00K | -530.00K | |||
| Other Income/Expense | 438.00K | 415.00K | -100.00K | 0.00 | 1.33M | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 0.00 | |||
| Income Before Taxes | -36.73M | -32.08M | -55.43M | -50.42M | -27.95M | |||
| Income Tax | N/A | 103.00K | 2.33M | -90.00K | -10.00K | |||
| Net Income | -36.84M | -32.18M | -57.76M | -50.33M | -27.94M | |||
| EBITDA | -50.78M | -43.67M | -57.55M | -49.24M | -28.17M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.68 | -0.64 | -1.73 | -1.98 | -1.34 | |||
| Non GAAP EPS | -0.67 | -0.67 | -1.68 | -1.98 | -1.38 | |||
| Statistics | ||||||||
| Profit Margin | -65.18% | -54.66% | -192.15% | -214.72% | -299.14% | |||
| Operating Profit Margin | -90.88% | -75.16% | -193.45% | -212.71% | -307.82% | |||
All data in USD